Johnson & Johnson will ask the FDA this week to approve a booster shot of its coronavirus vaccine, according to officials familiar with the company’s plans. Continue reading “Johnson & Johnson Will Request FDA Approval For Booster Shot”
A new study finds that giving a booster dose of the Johnson & Johnson shot six months after primary vaccination results in a 9x increase in antibody response. Continue reading “Data Shows J&J Booster Results In 9x Antibody Response”
On the eve of the 40th anniversary of the first AIDS diagnosis, the world remains caught in the grips of another frightening health epidemic – COVID.
Today, June 24, from 6:00-8:30PM EST, activist and actor Billy Porter – who just recently shared his own HIV diagnosis with the world – will join Michael Sneed, Johnson & Johnson’s EVP of Global Cultural Affairs (which in addition to helping the world fight COVID, is currently working on a HIV vaccine) for a free special screening of the award-winning documentary 5B.
The acclaimed documentary chronicles the stories of the heroic nurses who risked their lives to found the World’s first AIDS Ward.
Following the screening, Porter will chat with 5B nurse Alison Moëd Paolercio, and author Rebecca Love RN to discuss the disproportionate toll that epidemics and pandemics take on at-risk communities, the parallels between the HIV/AIDS and COVID-19 crises, and the role of nurses in driving healthcare change.
Not able to join the event? Visit 5Bfilm.com to find out where to stream the movie and, after the event, view the archived fireside chat at https://nursing.jnj.com/5B-fireside-chat-with-billy-porter.
Here’s the official trailer for 5B:
The Centers for Disease Control and Prevention hit the pause button for injections of the Johnson & Johnson coronavirus vaccine after 6 women developed a rare blood clotting disease.
From the New York Times:
All six were women between the ages of 18 and 48 and all developed the illness within one to three weeks of vaccination. One woman died and a second woman in Nebraska has been hospitalized in critical condition.
As of Monday, nearly seven million people in the United States have received Johnson & Johnson shots so far without any other serious adverse reactions reported, and roughly nine million more doses have been shipped out to the states, according to data from the Centers for Disease Control and Prevention.
At this point, there’s no hard evidence there’s a connection between the blood clotting and the J&J vaccine.
With 6 patients out of nearly 7 million vaccinated with the vaccine, experts point out the odds of getting COVID-19 are far greater.
But, the development is sure to cause even more vaccine hesitancy in those who were already unsure about getting vaccinated.
There are no reports that the Pfizer or Moderna vaccines – which are based on a different scientific approach – have been connected to similar blood clotting.
How worried should you be about the Johnson & Johnson vaccine and blood clots?
Experts have yet to determine to what extent, if any, the vaccine is related to an extremely rare clotting disorder, and said for most people, the benefits outweigh the risks. https://t.co/Es6o7pJFhZ
— The New York Times (@nytimes) April 13, 2021
Just 6 out of 7 million got blood clots from the Johnson & Johnson vaccine
316 people are shot in the U.S. every single day, 106 of them dying
By that logic, shouldn’t we halt guns, too?
— Lindy Li (@lindyli) April 13, 2021
Today, Dr. Fauci made a wonderful point on vaccine safety for those still hesitant:
The fact that the FDA and CDC decided to pause the Johnson & Johnson vaccine after ONLY 6 out of 6.8 million doses raised concern, it's proof of how stringent they are on overall vaccine safety.
— Jake Lobin (@JakeLobin) April 13, 2021
If you got the Johnson & Johnson vaccine, you apparently have less than one in a million chance of developing blood clots, and even then they're unlikely to be fatal.
Meanwhile, COVID has killed about one out of every five hundred Americans.
— Palmer Report (@PalmerReport) April 13, 2021
Car crashes kill 124 people per 1M every year, yet we give licenses to any teen with a pulse.
154 in a million people go to the ER for Tylenol ODs every year, yet that's OTC!
And yet we're halting the J&J vax because 6 in 6.8 million got a blood clot?https://t.co/dRrIQdgjVp
— Tiana Lowe (@TianaTheFirst) April 13, 2021
There’s going to be a big dip in Johnson & Johnson vaccine deliveries due to woeful failures at the contracted manufacturing plant in Maryland.
From the New York Times:
Johnson & Johnson will allocate 86 percent fewer doses across the United States next week than are currently being allocated, according to data provided by the Centers for Disease Control and Prevention, dealing a setback to a national vaccination campaign that has just found its footing.
The distribution of the drug, a single-shot vaccine, has been inconsistent since Johnson & Johnson delivered its first batch at the beginning of March, sending 2.8 million doses across the country before dipping below 400,000 in the following weeks.
Last month, Johnson & Johnson was forced to jettison up to 15 million doses manufactured at the factory because the batch had been contaminated with a virus used in the production of AstraZeneca’s vaccine, which is also manufactured there.
The Johnson & Johnson shot has been popular for it’s easier to store “one-and-done” single dose.
J & J had previously promised to deliver 24 million new doses by the end of April.
Johnson & Johnson will deliver 86% fewer doses across the U.S. next week, according to data provided by the CDC, dealing a setback to a national vaccination campaign that has just found its footing. https://t.co/kXtvL3yVUb
— The New York Times (@nytimes) April 9, 2021
During an appearance on Meet The Press today, Dr. Anthony Fauci was asked about differences between the Moderna and Pfizer coronavirus vaccines versus the newly-approved Johnson & Johnson vaccine.
The primary difference is the J&J vaccine is a single shot vaccination where the first two you have to return for a follow-up shot 3-4 weeks later. Also, the J&J vaccine can be shipped and stored at normal refrigerator temperatures compared to the other two which have to be stored frozen at ultra-cold temperatures.
The Pfizer and Moderna vaccines demonstrated higher efficacy rates in trials but Fauci says direct comparisons with the J&J vaccine is difficult because J&J’s was conducted as more contagious variants of the virus were circulating.
According to the New York Times, the FDA approved the J&J version this weekend following presentations showing the vaccine was 85 percent protective against severe Covid-19 disease across all clinical trial sites and provided 100% protection against hospitalizations and deaths.
“All three of them are really quite good, and people should take the one that’s most available to them,” Fauci told NBC News host Chuck Todd. “If you go to a place and you have J&J, and that’s the one that’s available now, I would take it.”
Dr. Fauci: “I would have no hesitancy whatsoever to take” the new single-shot vaccine. pic.twitter.com/IY9NesO26J
— Meet the Press (@MeetThePress) February 28, 2021
Pharmaceutical company Johnson & Johnson will soon begin testing an experimental HIV vaccine in the U.S. and Europe sometime this year, according to Bloomberg News.
The experimental vaccine, described as a “mosaic-based preventative immunization,” is made up of four components that target several strains the HIV virus.
The vaccine utilizes an altered cold virus to create a group of “mosaic” proteins that will elicit immune responses to a variety of strains.
Approximately 3,800 men who have sex with men are expected to take part in the trial expected to begin later this year. The participants will receive a series of six shots in four sessions.
Dan Barouch, a Harvard Medical School professor who has worked on the vaccine for years, told Bloomberg the J&J vaccine has provided protection in up to two-thirds of tested animals.
Additionally, another version of the mosaic vaccine is currently being tested across five countries in southern Africa. Some 2,600 women are enrolled in that study called “Imbokodo.”
According to J&J, “Imbokodo” is the Zulu word for ‘rock’ which is part of a well-known proverb in South Africa that refers to the strength of women and their importance in the community.
Results from Imbokodo are expected in 2021.